Application of causal inference methods in the analyses of randomised controlled trials: a systematic review
暂无分享,去创建一个
Jelena Savović | Daphne Kounali | Alison Richards | D. Kounali | M. May | J. Savović | A. Richards | R. Farmer | Deborah Ford | D. Ford | Ruth E. Farmer | A. Sarah Walker | Margaret T. May | A. Walker | A. Walker | Alison Richards
[1] J. Robins. A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .
[2] J. Robins,et al. Correcting for non-compliance in randomized trials using rank preserving structural failure time models , 1991 .
[3] J. Robins,et al. Recovery of Information and Adjustment for Dependent Censoring Using Surrogate Markers , 1992 .
[4] J. Robins,et al. G-Estimation of the Effect of Prophylaxis Therapy for Pneumocystis carinii Pneumonia on the Survival of AIDS Patients , 1992, Epidemiology.
[5] J. Robins. Correcting for non-compliance in randomized trials using structural nested mean models , 1994 .
[6] J. Robins,et al. Adjusting for differential rates of prophylaxis therapy for PCP in high- versus low-dose AZT treatment arms in an AIDS randomized trial , 1994 .
[7] J. Robins,et al. Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.
[8] James M. Robins,et al. Marginal Structural Models versus Structural nested Models as Tools for Causal inference , 2000 .
[9] J. Robins,et al. Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests , 2000, Biometrics.
[10] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[11] J. Robins,et al. Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized Treatments , 2001 .
[12] J M Robins,et al. Marginal Mean Models for Dynamic Regimes , 2001, Journal of the American Statistical Association.
[13] J. Robins,et al. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures , 2002, Statistics in medicine.
[14] S. Murphy,et al. Optimal dynamic treatment regimes , 2003 .
[15] Y. Ohashi,et al. Adjusting for differential proportions of second‐line treatment in cancer clinical trials. Part II: An application in a clinical trial of unresectable non‐small‐cell lung cancer , 2004, Statistics in medicine.
[16] James M. Robins,et al. Optimal Structural Nested Models for Optimal Sequential Decisions , 2004 .
[17] James M. Robins,et al. Association, Causation, And Marginal Structural Models , 1999, Synthese.
[18] E. Goetghebeur,et al. Structural accelerated failure time models for the effects of observed exposures on repeated events in a clinical trial , 2005, Statistics in medicine.
[19] J. Robins,et al. Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/pds.1064 , 2022 .
[20] Marshall M Joffe,et al. History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens , 2005 .
[21] M. J. van der Laan,et al. The International Journal of Biostatistics Causal Effect Models for Realistic Individualized Treatment and Intention to Treat Rules , 2011 .
[22] S. Fuchs,et al. Postnatal depression in Southern Brazil: prevalence and its demographic and socioeconomic determinants , 2008, BMC psychiatry.
[23] James M. Robins,et al. Observational Studies Analyzed Like Randomized Experiments: An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease , 2008, Epidemiology.
[24] Serena J Counsell,et al. Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans , 2008, BMC psychiatry.
[25] I. Lipkovich,et al. Evaluating dose response from flexible dose clinical trials , 2008, BMC psychiatry.
[26] Stephen R Cole,et al. Constructing inverse probability weights for marginal structural models. , 2008, American journal of epidemiology.
[27] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[28] N. Jewell,et al. Analysing direct effects in randomized trials with secondary interventions: an application to human immunodeficiency virus prevention trials , 2009 .
[29] M. Kramer,et al. Estimating Response-Maximized Decision Rules With Applications to Breastfeeding , 2009 .
[30] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[31] James M Robins,et al. Estimating Absolute Risks in the Presence of Nonadherence: An Application to a Follow-up Study With Baseline Randomization , 2010, Epidemiology.
[32] C. Gilks,et al. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort , 2010, The Lancet.
[33] B. Brumback,et al. Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] James M. Robins,et al. The International Journal of Biostatistics CAUSAL INFERENCE When to Start Treatment ? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data , 2011 .
[35] A. Young,et al. In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005 , 2010, European Psychiatry.
[36] T. Schuster,et al. Post-study therapy as a source of confounding in survival analysis of first-line studies in patients with advanced non-small-cell lung cancer. , 2011, Journal of thoracic disease.
[37] Eric M. Reyes,et al. Abstract 14642: Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study , 2012 .
[38] Peter F Thall,et al. Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer , 2012, Journal of the American Statistical Association.
[39] E. Porrini,et al. Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[40] S. Cole,et al. Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death. , 2012, American journal of epidemiology.
[41] Y. Ohashi,et al. Effective prevention of cardiovascular disease and diabetes‐related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: Adjusting for treatment changes using a marginal structural proportional hazards model and a rank‐preserving structural failure time model , 2012, Geriatrics & gerontology international.
[42] Li-sheng Liu,et al. Higher cardiovascular risk and impaired benefit of antihypertensive treatment in hypertensive patients requiring additional drugs on top of randomized therapy: is adding drugs always beneficial? , 2012, Journal of hypertension.
[43] C. Morrison,et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa , 2012, AIDS.
[44] Y. Yoshimasa,et al. Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early-stage diabetic patients. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[45] Min Zhang,et al. Estimating treatment effects from a randomized clinical trial in the presence of a secondary treatment. , 2012, Biostatistics.
[46] Brent A. Johnson,et al. Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095 , 2012, Journal of the American Statistical Association.
[47] N. Keiding,et al. Estimation of dynamic treatment strategies for maintenance therapy of children with acute lymphoblastic leukaemia: an application of history‐adjusted marginal structural models , 2012, Statistics in medicine.
[48] Peter Diem,et al. Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study , 2013, BMJ.
[49] Abdus S Wahed,et al. Evaluating joint effects of induction–salvage treatment regimes on overall survival in acute leukaemia , 2013, Journal of the Royal Statistical Society. Series C, Applied statistics.
[50] I. White,et al. Review of inverse probability weighting for dealing with missing data , 2013, Statistical methods in medical research.
[51] R. Cook,et al. Inverse probability weighted estimating equations for randomized trials in transfusion medicine , 2013, Statistics in medicine.
[52] A. van der Straten,et al. Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa , 2013, AIDS.
[53] Stephen R Cole,et al. An information criterion for marginal structural models , 2013, Statistics in medicine.
[54] B L De Stavola,et al. Methods for dealing with time‐dependent confounding , 2013, Statistics in medicine.
[55] Min Zhang,et al. Adjusting for observational secondary treatments in estimating the effects of randomized treatments. , 2013, Biostatistics.
[56] J. Robins. Structural Nested Failure Time Models , 2005 .
[57] D. Atar,et al. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. , 2014, European heart journal.
[58] J. Calabrese,et al. Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. , 2014, Journal of affective disorders.
[59] Peter Diem,et al. Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study , 2014, BMJ : British Medical Journal.
[60] A. Crook,et al. Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial , 2014, Human reproduction.
[61] The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models , 2015, American journal of epidemiology.
[62] Edward H Kennedy,et al. An introduction to g methods. , 2016, International journal of epidemiology.